MicroRNA: The Diamond in the Rough?

MicroRNA’s are very small endogenous, non-coding, oligonucleotides. They are implicated in regulating a broad range of biological processes. These are molecules which are involved in important regulation of biological processes, and the potential of using these molecules as targets for treatment is becoming ever more apparent. With increased interest from big pharma, it is now important to identify a handful of smallcap companies specializing in this field.

Read more »

2013, A Year for Point-of-Care Diagnostics Growth

Response Biomedical Corp. (RBM.TO)(RPBIF) is bringing in 2013 with a bang announcing their 2nd US distribution deal since the 1st week in January. Earlier in the month Response Biomedical entered a distribution agreement with US hospital supplier Laboratory Supply Company Inc. (Labsco) to distribute its cardiovascular portfolio of RAMP® products to small hospitals. By the end of January Response Biomedical announced their 2nd US distribution agreement with Fishers Healthcare for their RAMP® Flu A + B tests and RAMP® RSV test on the RAMP® 200.

Read more »

Release: Amarantus BioSciences Announces MANF Demonstrates Superiority over GDNF in Neurorestoration Behavioural Animal Model of Parkinson’s Disease

The following is a news release published October 25 by Amarantus BioSciences discussing positive behavioural efficacy data for MANF, the company’s powerful therapeutic protein with neuron-protective properties. Data from a neurorestoration 6-hydroxydopamine (6-OHDA) rat model Parkinson’s disease shows superiority of MANF over GDNF.

Read more »

Spotlight Back on Sudden Cardiac Arrest

Recent news reports of young American athletes collapsing on the field have drawn media attention to sudden cardiac arrest, a leading cause of death in the U.S.

Read more »

PAD Awareness Month Brings Often-Overlooked Cardiovascular Disease to the Forefront

While most people are familiar with the big-name heart problems such as cardiac arrest and congestive heart failure, PAD is often overlooked.

Read more »

The Latest Cardiology News

Cameron Health has released positive clinical trial data on a unique therapy to prevent sudden cardiac arrest, a leading cause of death in the U.S.

Read more »

Streamlining the Stenting Process with Svelte Medical

The company’s first product is a low-profile “Stent-On-a-Wire” system that reduces the number of steps involved in the stenting procedure.

Read more »

Dimera Fights the “Silent Killer”

According to the American Heart Association, heart disease is the number one killer of women over age 25–more than the next five causes of death, or all forms of cancer, combined.

Read more »